This story was originally published on Stuff "Why does New Zealand need to reinvent the wheel?" Posed by National MP Maggie Barry, that was the...
Myeloma NZ
Health Select Committee hears pleas from survivors and sufferers
This story was originally published on RNZ Politicians heard emotional pleas today from cancer survivors, people with disabilities and health...
Blood cancer patient advocacy group presents to Health Select Committee to fund life-extending treatments
Dr Ken Romeril, chief executive, Myeloma New Zealand, is appearing today before the Health Select Committee in support of their submission asking...
Overview of the Report – Assoc Professor Richard Milne
Click below to view presentation
The Way Forward – Dr David Simpson
Click below to view presentation
Key Treatment Priorities – Dr Ken Romeril
Click below to view presentation
Patients’ Perspective – Joy Wilkie
Kia ora koutou, kō Ngati Tarawhai me Ngaiterangi ngā iwi, kō Joy Wilkie ahau, Tēnā koutou katoa It’s great to be alive and here today. Thanks Dr...
Patients’ Perspective – Paul Crosbie
Click below to view presentation
Ken Romeril speech at the Burden of Disease launch 26 June, 2019
Welcome and introduction of Dr Liz Craig. No mai, haere mai: Dr Craig, Members of Parliament, colleagues, health sector professionals, patients and...
Dr. Nadeem on Individualizing Therapy in Multiple Myeloma
Omar Nadeem, MD, a physician at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School, discusses individualizing...
The VCAT study
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous...
Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system caused by reactivation of John...